A prospective observational study on the traditional and novel risk factors associated with post-transplant diabetes mellitus in renal transplant recipients


  • Krithika Muralidhara
  • Subramanian Kannan
  • Ishthiaque Ahamed
  • Krishna Kishore
  • Llyod Vincent
  • Nitin Hegde




Post Transplant Diabetes mellitus (PTDM), renal transplant, trace element, post-transplant transient Hyperglycemia (PTTH)


Introduction and Aim: Post Transplant Diabetes Mellitus (PTDM) constitutes a major co-morbidity that has significant impact on the patient and renal allograft outcome. Various traditional risk factors like dialysis vintage, immunosuppressive medication, viral infections have known to be associated with PTDM. Novel risk factors and its causative role in PTDM remains unexplored. The study looked at the incidence of PTDM at 6 months post renal transplantation and correlation of PTDM with known traditional and novel risk factors like pre-transplant C-reactive protein (CRP) level and Trace element deficiency.


Material and Methods: 30 consecutive renal transplant recipients more than 18 years of age were inducted into the study. Demographic data, known pre-transplant and post-transplant risk factors associated with development of PTDM were collected. Pre-transplant CRP and serum Trace element (Aluminum, Copper, Selenium and Zinc) levels were estimated. PTDM was diagnosed by home based glucometer monitoring and confirmed by Oral glucose tolerance test (OGTT).


Results: The incidence of PTDM was 36.6% at six months post renal transplant. Among the pre-transplant risk factors, higher age and positive family history of diabetes mellitus had a strong association with the occurrence of PTDM. Pre-transplant Zinc deficiency emerged as a significant novel risk factor for the development of PTDM.


Conclusion: Apart from known traditional risk factors, novel risk factors are associated with development of PTDM.

Author Biographies

Krithika Muralidhara

Department of Nephrology, St. John's Medical College Hospital, Bangalore, India

Subramanian Kannan

Department of Endocrinology, Narayana Hrudayalaya Hospitals Bangalore, India

Ishthiaque Ahamed

Department of Nephrology, Narayana Hrudayalaya Hospitals Bangalore, India

Krishna Kishore

Department of Nephrology, Narayana Hrudayalaya Hospitals Bangalore, India

Llyod Vincent

Department of Nephrology, Narayana Hrudayalaya Hospitals Bangalore, India

Nitin Hegde

Department of Nephrology, Narayana Hrudayalaya Hospitals Bangalore, India


Sharif, A., Hecking, M., de Vries, A. P., Porrini, E., Hornum, M., Rasoul, R. S., et al., Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant. 2014 Sep; 14(9): 1992-2000.

Pham, P. T., Pham, P. M., Pham, S. V., Pham, P. A., Pham, P. C. New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes. 2011; 4: 175-186.

Lakshminarayana, G. R., Sheetal, L. G., Anil, M. New Onset Diabetes after Renal Transplantation (NODAT): Prevalence, Risk Factors and Treatment. JMSCR. 2016 Jan; 04: 8969-8975.

Saboo, D., Shah, P. R., Goplani, K. R., Feroz, A., Gumber, M., Vanikar, A. V., et al., Posttransplant diabetes mellitus: a single-center study. Transplant Proc. 2008 May; 40(4): 1111-1113.

Patel, D. D., Modi, K. P., Patel, A. K., Chaudhary, V. New onset of diabetes mellitus in Indian renal transplant recipient-a retrospective study. International Journal of Pharmacy and Pharmaceutical Sciences. 2015; 7(11): 228-232.

Montori, V. M., Basu, A., Erwin, P. J., Velosa, J. A., Gabriel, S. E., Kudva, Y. C. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care. 2002 Mar;25(3): 583-592.

Cosio, F. G., Pesavento, T. E., Osei, K., Henry, M. L., Ferguson, R. M. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int. 2001 Feb; 59(2): 732-737.

Gourishankar, S., Jhangri, G. S., Tonelli, M., Wales, L. H., Cockfield, S. M. Development of diabetes mellitus following kidney transplantation: a Canadian experience. Am J Transplant. 2004 Nov; 4(11): 1876-1882.

Martínez, C. A., Hernández, M. D., Pascual, J., Morales, J. M., Marcen, R., Errasti, P., et al., Detection and treatment of post kidney transplant hyperglycemia: a Spanish multicenter cross-sectional study. Transplant Proc. 2005 Nov; 37(9): 3813-3816.

Davidson, J., Wilkinson, A., Dantal, J., Dotta, F., Haller, H., Hernández, D., et al., New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation. 2003 May 27; 75(10 Suppl): SS3- SS24.

Pirsch, J. D., Henning, A. K., First, M. R., Fitzsimmons, W., Gaber, A. O., Reisfield, R., et al., New-onset diabetes after transplantation: results from a double-blind early corticosteroid withdrawal trial. Am J Transplant. 2015 Jul; 15(7): 1982-1990.

Cantarin, M. P., Keith, S. W., Lin, Z., Doria, C., Frank, A. M., Maley, W. R., et al., Association of inflammation prior to kidney transplantation with post-transplant diabetes mellitus. Cardiorenal Med. 2016 Aug; 6(4): 289-300.

van Laecke, S., Nagler, E. V., Taes, Y., van Biesen, W., Peeters, P., Vanholder, R. The effect of magnesium supplements on early post-transplantation glucose metabolism: a randomized controlled trial. Transpl Int. 2014 Sep; 27(9): 895-902.

Jansen, J., Karges, W., Rink, L. Zinc and diabetes – Clinical links and molecular mechanisms. J Nutr Biochem. 2009; 20: 399 417.

Khan, A. R., Awan, F. R. Metals in the pathogenesis of type 2 diabetes. J Diabetes Metab Disord. 2014; 13: 16.

Chimienti, F., Favier, A., Seve, M. ZnT 8, a pancreatic beta cell specific zinc transporter. Biometals 2005; 18: 313 317.

Rungby, J. Zinc, zinc transporters and diabetes. Diabetologia. 2010; 53: 1549 1551.

Praveena, S., Pasula, S., Sameera, K. Trace elements in diabetes mellitus. J Clin Diagn Res. 2013 Sep; 7(9): 1863-1865.

Terrés, M. C., Navarro, A. M., Martín, L. F., López, G., Serrana, H., Pérez, V. V., et al., Serum zinc and copper concentrations and Cu/Zn ratios in patients with hepatopathies or diabetes. J Trace Elem Med Biol. 1998 Mar; 12(1): 44-49.

Basaki, M., Saeb, M., Nazifi, S., Shamsaei, H. A. Zinc, copper, iron, and chromium concentrations in young patients with type 2 diabetes mellitus. Biol Trace Elem Res. 2012 Aug; 148(2): 161-164.

Devi, T. R., Hijam, D., Dubey, A. Study of serum zinc and copper levels in type 2 diabetes mellitus. International Journal of Contemporary Medical Research. 2016; 3(4): 1036-1040.

Gunasekara, P., Hettiarachchi, M., Liyanage, C., Lekamwasam, S. Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes. Diabetes Metab Syndr Obes. 2011; 4: 53 60.

Foster, M., Petocz, P., Samman, S. Effects of zinc on plasma lipoprotein cholesterol concentrations in humans: A meta analysis of randomised controlled trials. Atherosclerosis. 2010; 210: 344 352.

Jayawardena, R., Ranasinghe, P., Galappatthy, P., Malkanthi, R., Constantine, G., Katulanda, P. Effects of zinc supplementation on diabetes mellitus: A systematic review and meta analysis. Diabetol Metab Syndr. 2012; 4: 13.

Chakkera, H. A., Knowler, W. C., Devarapalli, Y., Weil, E. J., Heilman, R. L., Dueck, A., et al., Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus. Clin J Am Soc Nephrol. 2010 Sep; 5(9): 1669-1675.

Maldonado, F., Tapia, G., Ardiles, L. Early hyperglycemia: a risk factor for posttransplant diabetes mellitus among renal transplant recipients. Transplant Proc. 2009 Jul-Aug; 41(6): 2664-2667.




How to Cite

Muralidhara K, Kannan S, Ahamed I, Kishore K, Vincent L, Hegde N. A prospective observational study on the traditional and novel risk factors associated with post-transplant diabetes mellitus in renal transplant recipients. Biomedicine [Internet]. 2021Sep.7 [cited 2021Sep.22];41(2):482-8. Available from: https://biomedicineonline.org/index.php/home/article/view/1063